Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase NA 11Phase 3 8Phase 1 4Phase 4 2Phase 2/3 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 60INDUSTRY 60NIH 8UNKNOWN 2NETWORK 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 8Breast Neoplasms 8Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 4Small Cell Lung Carcinoma 4Neoplasms 4Multiple Myeloma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Parasomnias 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Melanoma 2Lymphoma 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Head and Neck Neoplasms 2HIV Infections 2Fatigue 2Erectile Dysfunction 2Carcinoma, Hepatocellular 2Vitamin D Deficiency 1Uveal Melanoma 1Urinary Bladder Neoplasms 1Untreated Advanced Non-small Cell Lung Cancer 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1

Interventions

Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER_GOV × Esophageal Neoplasms × Clear all
NCT05937438 2025-01-29

Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

Anhui Provincial Hospital

Phase 1/2 Recruiting
70 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡